Home » Antares Pharma Announces Positive Results from VIBEX MTX Usability Study
Antares Pharma Announces Positive Results from VIBEX MTX Usability Study
Antares Pharma announced positive results from a human factors usability study for VIBEX Methotrexate, a proprietary auto injector product designed to self-administer a rapid subcutaneous weekly injection of methotrexate for the treatment of rheumatoid arthritis.
MarketWatch
MarketWatch
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May